CD32a polymorphism rs1801274 affects the risk of Kawasaki disease

Aim To analyze the impact of CD32a polymorphism rs1801274 on the occurrence of Kawasaki disease (KD) through the meta-analysis.Methods The correlation between CD32a polymorphism rs1801274 and the susceptibility to KD was appraised using summarized odds ratios (ORs) with their 95% confidence interval...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhiyong Wang, Pei-Liang Geng
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Artificial Cells, Nanomedicine, and Biotechnology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/21691401.2019.1645156
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849390695677165568
author Zhiyong Wang
Pei-Liang Geng
author_facet Zhiyong Wang
Pei-Liang Geng
author_sort Zhiyong Wang
collection DOAJ
description Aim To analyze the impact of CD32a polymorphism rs1801274 on the occurrence of Kawasaki disease (KD) through the meta-analysis.Methods The correlation between CD32a polymorphism rs1801274 and the susceptibility to KD was appraised using summarized odds ratios (ORs) with their 95% confidence intervals (95% CIs). Besides, stratification analyses were further implemented on the basis of ethnicity and control source, respectively. Between-study heterogeneity was checked adopting chi-square-based Q test, with p < .05 as significant level. And results from Q test determined which model would be employed for OR calculation, fixed- or random-effects. Sensitivity analysis was accomplished to test the stability of final results. Potential publication bias among included studies was investigated using Begg’s funnel plot and Egger’s test. If publication bias was significant, its influence on overall estimates would be measured adopting the trim-and-fill method.Results CD32a polymorphism rs1801274 significantly increased KD risk in total analysis under the comparisons of AA vs. GG, AA + AG vs. GG, AA vs. GG + AG, A vs. G and AG vs. GG (OR = 2.69, 95% CI = 1.39–5.20; OR = 2.00, 95% CI = 1.23–3.26; OR = 1.90, 95% CI = 1.23–2.94; OR = 1.77, 95% CI = 1.34–2.34; OR = 1.53, 95% CI = 1.07–2.19). After stratification analysis by ethnicity, similar tendency was also observed in Caucasian and Asian subgroups under corresponding genetic models. And parallel results were replicated in population-based and other-source subgroups after stratified analysis by control source, under some contrasts.Conclusion CD32a polymorphism rs1801274 has strong relation to KD onset, and the presence of its A allele could elevate the disease incidence.
format Article
id doaj-art-e07aa43aacf64ec9aed84a6d28efa532
institution Kabale University
issn 2169-1401
2169-141X
language English
publishDate 2020-01-01
publisher Taylor & Francis Group
record_format Article
series Artificial Cells, Nanomedicine, and Biotechnology
spelling doaj-art-e07aa43aacf64ec9aed84a6d28efa5322025-08-20T03:41:25ZengTaylor & Francis GroupArtificial Cells, Nanomedicine, and Biotechnology2169-14012169-141X2020-01-0148162062610.1080/21691401.2019.1645156CD32a polymorphism rs1801274 affects the risk of Kawasaki diseaseZhiyong Wang0Pei-Liang Geng1Department of Pediatrics, Weifang Maternal and Child Health Hospital, Weifang, ChinaCenter for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, ChinaAim To analyze the impact of CD32a polymorphism rs1801274 on the occurrence of Kawasaki disease (KD) through the meta-analysis.Methods The correlation between CD32a polymorphism rs1801274 and the susceptibility to KD was appraised using summarized odds ratios (ORs) with their 95% confidence intervals (95% CIs). Besides, stratification analyses were further implemented on the basis of ethnicity and control source, respectively. Between-study heterogeneity was checked adopting chi-square-based Q test, with p < .05 as significant level. And results from Q test determined which model would be employed for OR calculation, fixed- or random-effects. Sensitivity analysis was accomplished to test the stability of final results. Potential publication bias among included studies was investigated using Begg’s funnel plot and Egger’s test. If publication bias was significant, its influence on overall estimates would be measured adopting the trim-and-fill method.Results CD32a polymorphism rs1801274 significantly increased KD risk in total analysis under the comparisons of AA vs. GG, AA + AG vs. GG, AA vs. GG + AG, A vs. G and AG vs. GG (OR = 2.69, 95% CI = 1.39–5.20; OR = 2.00, 95% CI = 1.23–3.26; OR = 1.90, 95% CI = 1.23–2.94; OR = 1.77, 95% CI = 1.34–2.34; OR = 1.53, 95% CI = 1.07–2.19). After stratification analysis by ethnicity, similar tendency was also observed in Caucasian and Asian subgroups under corresponding genetic models. And parallel results were replicated in population-based and other-source subgroups after stratified analysis by control source, under some contrasts.Conclusion CD32a polymorphism rs1801274 has strong relation to KD onset, and the presence of its A allele could elevate the disease incidence.https://www.tandfonline.com/doi/10.1080/21691401.2019.1645156Kawasaki diseaseFcγ receptorFcγRIIACD32apolymorphism
spellingShingle Zhiyong Wang
Pei-Liang Geng
CD32a polymorphism rs1801274 affects the risk of Kawasaki disease
Artificial Cells, Nanomedicine, and Biotechnology
Kawasaki disease
Fcγ receptor
FcγRIIA
CD32a
polymorphism
title CD32a polymorphism rs1801274 affects the risk of Kawasaki disease
title_full CD32a polymorphism rs1801274 affects the risk of Kawasaki disease
title_fullStr CD32a polymorphism rs1801274 affects the risk of Kawasaki disease
title_full_unstemmed CD32a polymorphism rs1801274 affects the risk of Kawasaki disease
title_short CD32a polymorphism rs1801274 affects the risk of Kawasaki disease
title_sort cd32a polymorphism rs1801274 affects the risk of kawasaki disease
topic Kawasaki disease
Fcγ receptor
FcγRIIA
CD32a
polymorphism
url https://www.tandfonline.com/doi/10.1080/21691401.2019.1645156
work_keys_str_mv AT zhiyongwang cd32apolymorphismrs1801274affectstheriskofkawasakidisease
AT peilianggeng cd32apolymorphismrs1801274affectstheriskofkawasakidisease